GSK Net Income Growth
GSK plc American Depositary Shares (Each representing two Ordinary Shares) · Net Income Growth
GSK Net Income Growth
Year-over-year change vs the same period a year earlier
Latest reported40.84%period ending
GSK TTM Net Income YoY % (27.67% → 40.84%)
Year-over-year change
High-resolution chart · PNG
GSK net income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Net Income Growth |
|---|---|
| 40.8414% | |
| 84.8716% | |
| 121.9806% | |
| 118.7973% | |
| -15.1252% | |
| -29.6833% | |
| -47.7476% | |
| -58.4203% | |
| -73.8049% | |
| -69.3087% | |
| -66.9749% | |
| -57.5018% | |
| 223.6494% | |
| 174.9341% | |
| 225.4526% | |
| 214.8682% | |
| 8.3846% | |
| 1.0843% | |
| -20.247% | |
| -29.1634% | |
| -34.2866% | |
| -2.2862% | |
| 23.7675% | |
| 39.6843% | |
| 50.8697% | |
| 37.8074% | |
| 28.2087% | |
| 144.9517% | |
| 167.3309% | |
| 277.1981% | |
| 136.4883% | |
| -20.257% | |
| -14.2413% | |
| -38.2458% | |
| 67.9825% | |
| 675.7475% | |
| 6,129.0323% | |
| 172.5203% | |
| -89.1712% | |
| -96.9314% | |
| -99.6795% | |
| -93.957% | |
| 205.5878% | |
| 134.4407% | |
| 103.5354% | |
| 97.8806% | |
| -49.301% | |
| 8.9867% | |
| 19.5472% | |
| 23.3925% | |
| 20.3987% | |
| -21.701% | |
| -23.2032% | |
| -17.3672% | |
| -14.1798% | |
| 47.7252% | |
| 60.2973% | |
| 177.2952% | |
| 221.9706% | |
| -16.0597% | |
| -19.2952% | |
| -68.3101% | |
| -70.4574% | |
| -19.6015% | |
| -13.2104% | |
| 28.6707% | |
| 19.2797% | |
| 5.0409% | |
| -7.15% | |
| -10.9936% | |
| -11.1515% | |
| -12.263% | |
| -8.3505% | |
| -7.185% | |
| -3.1092% | |
| 0.1625% | |
| 5.32% | |
| 7.666% | |
| 14.1925% | |
| 10.82% | |
| 11.6032% | |
| 11.1943% | |
| 8.5476% | |
| 22.7445% | |
| 13.1774% | |
| 4.7858% | |
| -2.9642% | |
| -15.5152% | |
| -4.4505% | |
| 4.4858% | |
| 13.8074% | |
| 16.1967% | |
| 19.1239% | |
| 20.2572% | |
| 26.9442% | |
| 3.7117% | |
| -15.158% | |
| -15.8076% | |
| -25.5217% | |
| 33.6137% |